MODELLING THE EFFECTIVENESS OF SUBDERMALLY IMPLANTED BUPRENORPHINE, INJECTABLE NALTREXONE, AND SUBLINGUAL BUPRENORPHINE FOR CLINICALLY STABLE ADULTS WITH OPIOID DEPENDENCE. Issue 4 (December 2016)